The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today
GALILEO Trial
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement | NEJM
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study - ScienceDirect
GALILEO Trial
On Trial for Reason: Science, Religion, and Culture in the Galileo Affair, by Maurice Finocchiaro | Times Higher Education (THE)
UpToDate - The GALILEO trial, which included >1,600 patients who underwent transcatheter aortic valve implantation (TAVI), was stopped early because of higher rates of mortality and major bleeding among patients randomly assigned
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO
GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm | tctmd.com
GALILEO 4D - STUDY DESIGN
Clinical Trial Results in MEfRVO | EYLEA® (aflibercept) Injection
OAC in TAVR: Failed Galileo
ESC 365 - Doctor Georg Marcus Froehlich
PDF) Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
Bayer: GALILEO Trial Halted Early Due To Increased Mortality, Events - Docwire News
Results of the GALILEO trial (intention-to-treat analysis). | Download Scientific Diagram
OAC in TAVR: Failed Galileo
Galileo
Galileo Research Fact Sheet #138: Can Galileo Therapy decrease the development of Scoliosis? - Novotec Medical und Stratec Medizintechnik GmbH
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement | NEJM
Bayer: GALILEO Trial Halted Early Due To Increased Mortality, Events - Docwire News
Optimal Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: Is the “Less Is More” Concept Always Better? | Journal of the American Heart Association
Results of the GALILEO trial (intention-to-treat analysis). | Download Scientific Diagram
Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR | tctmd.com
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement | NEJM
Anticoagulation Therapy in Patients Post-TAVR - ppt download
GALILEO
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement | NEJM
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement | NEJM
